Compare, Analyse NEULAND LABS with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NEULAND LABS   MYLAN
EQUITY SHARE DATA
    NEULAND LABS
Mar-20
MYLAN
Dec-18
NEULAND LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs7543,554-   
Low Rs2471,956-   
Sales per share (Unadj.) Rs594.51,635.5-  
Earnings per share (Unadj.) Rs12.644.4-  
Cash flow per share (Unadj.) Rs37.0350.6-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs553.41,769.3-  
Shares outstanding (eoy) m12.83514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.81.7 50.0%   
Avg P/E ratio x39.662.0 63.9%  
P/CF ratio (eoy) x13.57.9 172.1%  
Price / Book Value ratio x0.91.6 58.1%  
Dividend payout %15.80-   
Avg Mkt Cap Rs m6,4211,417,614 0.5%   
No. of employees `0001.335.0 3.7%   
Total wages/salary Rs m1,2360-   
Avg. sales/employee Rs Th5,949.424,041.6 24.7%   
Avg. wages/employee Rs Th963.80-   
Avg. net profit/employee Rs Th126.4652.8 19.4%   
INCOME DATA
Net Sales Rs m7,627841,456 0.9%  
Other income Rs m390-   
Total revenues Rs m7,666841,456 0.9%   
Gross profit Rs m1,019217,738 0.5%  
Depreciation Rs m313157,554 0.2%   
Interest Rs m21640,471 0.5%   
Profit before tax Rs m52919,713 2.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m367-3,136 -11.7%   
Profit after tax Rs m16222,849 0.7%  
Gross profit margin %13.425.9 51.6%  
Effective tax rate %69.4-15.9 -436.1%   
Net profit margin %2.12.7 78.3%  
BALANCE SHEET DATA
Current assets Rs m5,152469,868 1.1%   
Current liabilities Rs m3,576342,586 1.0%   
Net working cap to sales %20.715.1 136.6%  
Current ratio x1.41.4 105.0%  
Inventory Days Days10584 125.7%  
Debtors Days Days9193 97.4%  
Net fixed assets Rs m3,969163,229 2.4%   
Share capital Rs m129448 28.8%   
"Free" reserves Rs m6,9710-   
Net worth Rs m7,100910,302 0.8%   
Long term debt Rs m774982,508 0.1%   
Total assets Rs m12,3102,441,784 0.5%  
Interest coverage x3.51.5 232.2%   
Debt to equity ratio x0.11.1 10.1%  
Sales to assets ratio x0.60.3 179.8%   
Return on assets %3.12.6 118.4%  
Return on equity %2.32.5 91.0%  
Return on capital %9.53.2 297.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,5940-   
CASH FLOW
From Operations Rs m573174,855 0.3%  
From Investments Rs m-487-90,381 0.5%  
From Financial Activity Rs m-55-81,458 0.1%  
Net Cashflow Rs m331,449 2.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.67 Rs / USD

Compare NEULAND LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare NEULAND LABS With: CIPLA  AJANTA PHARMA  SUVEN LIFE SCIENCES  ALEMBIC PHARMA  FDC  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views On News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NEULAND LABS SHARE PRICE


Apr 9, 2021 (Close)

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NEULAND LABS

NEULAND LABS 5-YR ANALYSIS

COMPARE NEULAND LABS WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS